61476-95-7

Upstream product

• 536-57-2 p-toluene sulfinic acid 
• 78-94-4 methyl vinyl ketone 

Downstream Products

• 594858-91-0 2-methyl-2-[2-(toluene-4-sulfonyl)-heptyl]-[1,3]dioxolane 
• 106369-12-4 2-Methyl-2-[4-phenyl-2-(toluene-4-sulfonyl)-butyl]-[1,3]dioxolane 
• 594858-93-2 2-methyl-2-[2-phenethyl-2-(toluene-4-sulfonyl)-pent-4-enyl]-[1,3]dioxolane 
• 594858-97-6 4-[1,3]dithiolan-2-ylmethyl-6-phenyl-4-(toluene-4-sulfonyl)-hexan-2-one 
• 594858-95-4 3-(2-methyl-[1,3]dioxolan-2-ylmethyl)-5-phenyl-3-(toluene-4-sulfonyl)-pentanal 
• 594858-92-1 2-methyl-2-[2-pentyl-2-(toluene-4-sulfonyl)-pent-4-enyl]-[1,3]dioxolane 
• 594858-96-5 4-[1,3]dithiolan-2-ylmethyl-4-(toluene-4-sulfonyl)-nonan-2-one 
• 594858-94-3 3-(2-methyl-[1,3]dioxolan-2-ylmethyl)-3-(toluene-4-sulfonyl)-octanal 
• 594858-99-8 5-oxo-3-phenethyl-3-[(4-methylphenyl)sulfonyl]hexanal 
• 594858-98-7 3-(2-oxo-propyl)-3-(toluene-4-sulfonyl)-octanal 

Relevant academic research and scientific papers

CERTAIN 1-AZABICYCLO[2.2.1]HEPTANES AND 1-AZABICYCLO[2.2.2]OCTANES

Novel compounds of formula (I), processes for their preparation, and their use as pharmaceutical agents are described: STR1 in which p represents an integer of 2 to 4; r represents an integer of 1 or 2; s represents 0 or 1; and X represents a group STR2 i

Novel compounds

A compound of formula (I) or a pharmaceutically acceptable salt thereof: STR1 in which X represents R1 OOC-- in which R1 is C1-4 alkyl, C2-4 alkenyl or C2-4 alkynyl; R2 O-- in which R2